403 related articles for article (PubMed ID: 21802334)
1. [Preoperative radiochemotherapy for rectal cancer: forecasting the next steps through ongoing and forthcoming studies].
Créhange G; Bosset JF; Maingon P
Cancer Radiother; 2011 Oct; 15(6-7):440-4. PubMed ID: 21802334
[TBL] [Abstract][Full Text] [Related]
2. [Chemotherapy and rectal cancer].
Michel P; Di Fiore F
Cancer Radiother; 2011 Oct; 15(6-7):436-9. PubMed ID: 21885319
[TBL] [Abstract][Full Text] [Related]
3. Cetuximab and chemoradiation for rectal cancer--is the water getting muddy?
Glynne-Jones R; Mawdsley S; Harrison M
Acta Oncol; 2010 Apr; 49(3):278-86. PubMed ID: 20180626
[TBL] [Abstract][Full Text] [Related]
4. Integration of novel agents into combined-modality treatment for rectal cancer patients.
Rödel C; Sauer R
Strahlenther Onkol; 2007 May; 183(5):227-35. PubMed ID: 17497093
[TBL] [Abstract][Full Text] [Related]
5. Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer.
Sastre J; Custodio A; Sanchez JC; Ortega L; Rodriguez L; Puente J; Corona J; Alfonso R; de las Heras M; Dıaz-Rubio E
Anticancer Drugs; 2011 Feb; 22(2):185-90. PubMed ID: 21218606
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemoradiation for rectal cancer: is more better?
Patel A; Puthillath A; Yang G; Fakih MG
Oncology (Williston Park); 2008 Jun; 22(7):814-26; discussion 826, 828-31, 836. PubMed ID: 18619122
[TBL] [Abstract][Full Text] [Related]
7. Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C).
Dewdney A; Cunningham D; Tabernero J; Capdevila J; Glimelius B; Cervantes A; Tait D; Brown G; Wotherspoon A; Gonzalez de Castro D; Chua YJ; Wong R; Barbachano Y; Oates J; Chau I
J Clin Oncol; 2012 May; 30(14):1620-7. PubMed ID: 22473163
[TBL] [Abstract][Full Text] [Related]
8. Combined-modality therapy for rectal cancer: future prospects.
Czito BG; Willett CG; Bendell JC
Clin Colorectal Cancer; 2007 Sep; 6(9):625-33. PubMed ID: 17945034
[TBL] [Abstract][Full Text] [Related]
9. Preoperative radiotherapy of advanced rectal cancer with capecitabine and oxaliplatin with or without cetuximab: A pooled analysis of three prospective phase I-II trials.
Weiss C; Arnold D; Dellas K; Liersch T; Hipp M; Fietkau R; Sauer R; Hinke A; Rödel C
Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):472-8. PubMed ID: 20133081
[TBL] [Abstract][Full Text] [Related]
10. Combined modality treatment for rectal cancer.
Zhu AX; Willett CG
Semin Oncol; 2005 Feb; 32(1):103-12. PubMed ID: 15726512
[TBL] [Abstract][Full Text] [Related]
11. [Principles of postoperative therapy in rectal carcinoma].
Folprecht G; Köhne CH
Chirurg; 2004 Jan; 75(1):32-7. PubMed ID: 14740125
[TBL] [Abstract][Full Text] [Related]
12. The use of capecitabine in the combined-modality therapy for rectal cancer.
Liauw SL; Minsky BD
Clin Colorectal Cancer; 2008 Mar; 7(2):99-104. PubMed ID: 18501068
[TBL] [Abstract][Full Text] [Related]
13. A prospective pilot study of target-guided personalized chemotherapy with intensity-modulated radiotherapy in patients with early rectal cancer.
Cubillo A; Hernando-Requejo O; García-García E; Rodriguez-Pascual J; De Vicente E; Morelli P; Rubio C; López-Ríos F; Muro A; López U; Prados S; Quijano Y; Hidalgo M
Am J Clin Oncol; 2014 Apr; 37(2):117-21. PubMed ID: 23211222
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives.
Corvò R; Pastrone I; Scolaro T; Marcenaro M; Berretta L; Chiara S
Tumori; 2003; 89(4):361-7. PubMed ID: 14606636
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial.
Allegra CJ; Yothers G; O'Connell MJ; Beart RW; Wozniak TF; Pitot HC; Shields AF; Landry JC; Ryan DP; Arora A; Evans LS; Bahary N; Soori G; Eakle JF; Robertson JM; Moore DF; Mullane MR; Marchello BT; Ward PJ; Sharif S; Roh MS; Wolmark N
J Natl Cancer Inst; 2015 Nov; 107(11):. PubMed ID: 26374429
[TBL] [Abstract][Full Text] [Related]
16. Current status of adjuvant therapy for colorectal cancer.
O'Connell MJ
Oncology (Williston Park); 2004 May; 18(6):751-5; discussion 755-8. PubMed ID: 15214594
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE. A randomised phase III trial of control vs. capecitabine plus oxaliplatin.
Glynne-Jones R; Meadows H; Wood W
Clin Oncol (R Coll Radiol); 2007 Jun; 19(5):327-9. PubMed ID: 17434299
[No Abstract] [Full Text] [Related]
18. Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer.
Hofheinz RD; Horisberger K; Woernle C; Wenz F; Kraus-Tiefenbacher U; Kähler G; Dinter D; Grobholz R; Heeger S; Post S; Hochhaus A; Willeke F
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1384-90. PubMed ID: 16979839
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial.
Schrag D; Weiser MR; Goodman KA; Gonen M; Hollywood E; Cercek A; Reidy-Lagunes DL; Gollub MJ; Shia J; Guillem JG; Temple LK; Paty PB; Saltz LB
J Clin Oncol; 2014 Feb; 32(6):513-8. PubMed ID: 24419115
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer: mature results of a phase II trial.
Dunst J; Debus J; Rudat V; Wulf J; Budach W; Hoelscher T; Reese T; Mose S; Roedel C; Zuehlke H; Hinke A
Strahlenther Onkol; 2008 Sep; 184(9):450-6. PubMed ID: 19016023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
